Why is Astec Lifescienc falling/rising?

As of 22-Aug, Astec Lifesciences Ltd is experiencing a significant rise in its stock price, currently at 913.00, reflecting an increase of 96.65 or 11.84%. The stock has shown a positive performance today, outperforming its sector by 11.66% and reversing a trend after two consecutive days of decline. It reached an intraday high of Rs 919, indicating strong trading activity, although the stock has also shown a wide trading range of Rs 102.95. Despite this upward movement, the company faces challenges, including operating losses and a high Debt to EBITDA ratio of 2.64 times, which suggests a weak long-term fundamental strength. Additionally, the company has reported negative results for the last five consecutive quarters, contributing to a significant decline in profitability over the past year.
In the broader market context, Astec Lifesciences has outperformed the benchmark Sensex in the short term, with a weekly return of +11.45% compared to the Sensex's +0.88%. However, the stock's year-to-date performance remains negative at -9.15%, contrasting with the Sensex's positive return of +4.05%. This consistent underperformance over the last three years, alongside a decline in investor participation, indicates underlying risks despite the recent price increase. The stock's liquidity remains adequate for trading, but the overall negative sentiment surrounding its financial health and historical performance may temper the enthusiasm generated by today's price movement.